Skip to main content

Afluria FDA Approval History

Last updated by Judith Stewart, BPharm on Jan 28, 2021.

FDA Approved: Yes (First approved September 28, 2007)
Brand name: Afluria
Generic name: influenza virus vaccine, inactivated
Dosage form: Injection
Company: Seqirus
Treatment for: Influenza Prophylaxis

Afluria is an inactivated influenza virus vaccine indicated for active immunization against influenza disease in persons 6 months of age and older.

Development timeline for Afluria

Oct 23, 2018Approval Seqirus Receives FDA Approval of Afluria and Afluria Quadrivalent (Influenza Vaccine) for People Six Months of Age and Older in the U.S.
Sep 28, 2007Approval CSL Biotherapies Announces FDA Marketing Approval of Afluria

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.